Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Xenobiotics and Loss of Cell Adhesion Drive Distinct Transcriptional Outcomes by Aryl Hydrocarbon Receptor Signaling

Nan Hao, Kian Leong Lee, Sebastian G. B. Furness, Cecilia Bosdotter, Lorenz Poellinger and Murray L. Whitelaw
Molecular Pharmacology December 2012, 82 (6) 1082-1093; DOI: https://doi.org/10.1124/mol.112.078873
Nan Hao
School of Molecular and Biomedical Science (Biochemistry) and Australian Research Council Special Research Centre for the Molecular Genetics of Development, the University of Adelaide, Adelaide, South Australia, Australia (N.H., M.L.W.); Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore (K.L.L., L.P.); Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia (S.G.B.F.); and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden (C.B., L.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kian Leong Lee
School of Molecular and Biomedical Science (Biochemistry) and Australian Research Council Special Research Centre for the Molecular Genetics of Development, the University of Adelaide, Adelaide, South Australia, Australia (N.H., M.L.W.); Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore (K.L.L., L.P.); Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia (S.G.B.F.); and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden (C.B., L.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastian G. B. Furness
School of Molecular and Biomedical Science (Biochemistry) and Australian Research Council Special Research Centre for the Molecular Genetics of Development, the University of Adelaide, Adelaide, South Australia, Australia (N.H., M.L.W.); Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore (K.L.L., L.P.); Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia (S.G.B.F.); and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden (C.B., L.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia Bosdotter
School of Molecular and Biomedical Science (Biochemistry) and Australian Research Council Special Research Centre for the Molecular Genetics of Development, the University of Adelaide, Adelaide, South Australia, Australia (N.H., M.L.W.); Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore (K.L.L., L.P.); Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia (S.G.B.F.); and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden (C.B., L.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorenz Poellinger
School of Molecular and Biomedical Science (Biochemistry) and Australian Research Council Special Research Centre for the Molecular Genetics of Development, the University of Adelaide, Adelaide, South Australia, Australia (N.H., M.L.W.); Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore (K.L.L., L.P.); Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia (S.G.B.F.); and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden (C.B., L.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Murray L. Whitelaw
School of Molecular and Biomedical Science (Biochemistry) and Australian Research Council Special Research Centre for the Molecular Genetics of Development, the University of Adelaide, Adelaide, South Australia, Australia (N.H., M.L.W.); Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore (K.L.L., L.P.); Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia (S.G.B.F.); and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden (C.B., L.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Abstract

The aryl hydrocarbon receptor (AhR) is a signal-regulated transcription factor, which is canonically activated by the direct binding of xenobiotics. In addition, switching cells from adherent to suspension culture also activates the AhR, representing a nonxenobiotic, physiological activation of AhR signaling. Here, we show that the AhR is recruited to target gene enhancers in both ligand [isopropyl-2-(1,3-dithietane-2-ylidene)-2-[N-(4-methylthiazol-2-yl)carbamoyl]acetate (YH439)]-treated and suspension cells, suggesting a common mechanism of target gene induction between these two routes of AhR activation. However, gene expression profiles critically differ between xenobiotic- and suspension-activated AhR signaling. Por and Cldnd1 were regulated predominantly by ligand treatments, whereas, in contrast, ApoER2 and Ganc were regulated predominantly by the suspension condition. Classic xenobiotic-metabolizing AhR targets such as Cyp1a1, Cyp1b1, and Nqo1 were regulated by both ligand and suspension conditions. Temporal expression patterns of AhR target genes were also found to vary, with examples of transient activation, transient repression, or sustained alterations in expression. Furthermore, sequence analysis coupled with chromatin immunoprecipitation assays and reporter gene analysis identified a functional xenobiotic response element (XRE) in the intron 1 of the mouse Tiparp gene, which was also bound by hypoxia-inducible factor-1α during hypoxia and features a concatemer of four XRE cores (GCGTG). Our data suggest that this XRE concatemer site concurrently regulates the expression of both the Tiparp gene and its cis antisense noncoding RNA after ligand- or suspension-induced AhR activation. This work provides novel insights into how AhR signaling drives different transcriptional programs via the ligand versus suspension modes of activation.

Footnotes

  • ↵Embedded Image The online version of this article (available at http://molpharm.aspetjournals.org) contains supplemental material.

  • This work was supported by the Australian Research Council and National Health and the Medical Research Council of Australia, the Singapore National Research Foundation and the Singapore Ministry of Education under the Research Centre of Excellence Programme, and the Swedish Research Council, the Swedish Cancer Society, and the European Union (FP 7, SYSTEQ).

  • Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.

    http://dx.doi.org/10.1124/mol.112.078873.

  • ABBREVIATIONS:

    AhR
    aryl hydrocarbon receptor
    bHLH
    basic helix-loop-helix
    PAS
    Per-Arnt-Sim homology
    HAH
    halogenated aromatic hydrocarbons
    YH439
    isopropyl-2-(1,3-dithietane-2-ylidene)-2-[N-(4-methylthiazol-2-yl)carbamoyl]acetate
    Hsp90
    heat shock protein 90
    Arnt
    aryl hydrocarbon receptor nuclear translocator
    XRE
    xenobiotic response elements
    TCDD
    2,3,7,8-tetrachlorodibenzo-p-dioxin
    pML
    major late promotor
    bp
    base pair(s)
    PCR
    polymerase chain reaction
    m
    mouse
    HEK
    human embryonic kidney
    shRNA
    short hairpin RNA
    DMSO
    dimethyl sulfoxide
    qRT
    quantitative real-time
    ChIP
    chromatin Immunoprecipitation
    HIF
    hypoxia-inducible factor
    ncRNA
    noncoding RNA
    kb
    kilobase(s)
    TSS
    transcription start site
    HRE
    hypoxia response element
    PTM
    post-translational modification.

  • Received March 22, 2012.
  • Accepted August 30, 2012.
  • Copyright © 2012 The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 82 (6)
Molecular Pharmacology
Vol. 82, Issue 6
1 Dec 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Xenobiotics and Loss of Cell Adhesion Drive Distinct Transcriptional Outcomes by Aryl Hydrocarbon Receptor Signaling
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Xenobiotic and Suspension Activation of AhR

Nan Hao, Kian Leong Lee, Sebastian G. B. Furness, Cecilia Bosdotter, Lorenz Poellinger and Murray L. Whitelaw
Molecular Pharmacology December 1, 2012, 82 (6) 1082-1093; DOI: https://doi.org/10.1124/mol.112.078873

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Xenobiotic and Suspension Activation of AhR

Nan Hao, Kian Leong Lee, Sebastian G. B. Furness, Cecilia Bosdotter, Lorenz Poellinger and Murray L. Whitelaw
Molecular Pharmacology December 1, 2012, 82 (6) 1082-1093; DOI: https://doi.org/10.1124/mol.112.078873
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of the selective action of paraherquamide A
  • Use-Dependent Relief of A-887826 Inhibition
  • Benzbromarone Relaxes Airway Smooth Muscle via BK Activation
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics